Thermedical wins FDA nod for Durablate catheter trial
Thermedical said today that it won an investigational device exemption from the FDA for a clinical trial of its Durablate catheter for treating ventricular tachycardia. The Durablate catheter is designed to simultaneously inject hot saline and use radiofrequency energy to effect the ablation; the Thermedical claims that the method is 20 times more effective than conventional RF ablation. The Waltham, Mass.-based company said the 30-patient early feasibility study is designed for patients already implanted with an implantable cardioverter defibrillator who’ve also had a conventional VT ablation procedure tha...
Source: Mass Device - July 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Catheters Clinical Trials atrial fibrillation Thermedical Source Type: news

Bioelectronics: A New era in Medical Care Is on the Horizon
Bioelectronics, generally defined, isn't new. Doctors Rune Elmqvist and Ake Senning implanted the first pacemaker in 1958. FDA approved the first spinal cord stimulator (SCS) in 1989. While both solutions continue to help patients worldwide, smaller, more advanced technology has pushed bioelectronics into a new era. Researchers have developed novel methods to use electrical impulses to regulate the brain and/or nervous system, resulting in highly targeted, effective treatment. "While SCS benefits last as long as the device stimulates, and the pacemaker continually keeps the heart on path, we treat and hope to modify t...
Source: MDDI - July 25, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: Implants Electronics Source Type: news

A case of life-threatening loperamide toxicity
3 out of 5 stars Severe loperamide toxicity associated with the use of cimetidine to potentiate the “high.” Hughes A et al. AM J Emerg Med 2018 May 15 [Epub ahead of print] Reference The potential adverse effects of loperamide (Imodium) are often underestimated since, even though it is an opioid, it is available over-the-counter and has been since 1988. Loperamide is used to treat diarrhea. It acts on the mu-opioid receptors in the gut, decreasing gastric motility. It is rather effective at this. However at therapeutic doses (2-16 mg per day) it does not cause central opioid effects such as euphoria or rel...
Source: The Poison Review - May 24, 2018 Category: Toxicology Authors: Leon Gussow Tags: Medical imodium loperamide overdose toxicity Source Type: news

Marijuana Use Not Linked to Risk of Arrhythmias After Acute MI
WEDNESDAY, May 9, 2018 -- For patients with acute myocardial infarction (AMI), marijuana use is not associated with increased risk of ventricular tachycardia/ventricular fibrillation (VT/VF) or cardiac arrest, according to a study presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2018 Category: Pharmaceuticals Source Type: news

Infographic: The heart out of rhythm
Learn more about?ventricular tachycardia. Other health tip infographics: mayohealthhighlights.startribune.com? (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 2, 2018 Category: Databases & Libraries Source Type: news

Could BioSig Play a Vital Role in the Bioelectronics Market?
BioSig Technologies is hoping to make an impact in the $4.6 billion electrophysiology (EP) market with its first product offering. The Santa Monica, CA-based company is developing the Pure EP system, a surface electrocardiogram and intracardiac multichannel device. BioSig filed said it filed for FDA clearance of the Pure EP system in late March. Once the company receives FDA clearance then it would turn its attention toward gaining regulatory clearance in Europe. “We feel like we’ve made a very robust submission to FDA,” Ken Londoner, founder and CEO of BioSig, told MD+DI. The Pure EP Syste...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Digital Health Source Type: news

Fatal flecainide intoxication in a 17-year-old girl - Dokter M, Talarico G, Armbrust S, Below E, Bockholdt B.
A  17-year-old girl was found vomiting and somnolent at home and was taken to a hospital. The girl initially presented with ventricular tachycardia with broad QRS complexes which was very difficult to control. During the course a subsequent cardiogenic sh... (Source: SafetyLit)
Source: SafetyLit - April 2, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Medical News Today: What is torsades de pointes?
Torsades de pointes is an uncommon type of ventricular tachycardia that can be potentially life-threatening. Learn more about the causes and diagnosis. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 15, 2018 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Stereotactic Body Radiation Can Cut Ventricular Tachycardia
Reduction from baseline of 99.9 percent in episodes of ventricular tachycardia in five patients (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - December 14, 2017 Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Pathology, Pulmonology, Radiology, Journal, Source Type: news

Focused Radiation May Nearly Erase Ventricular Tachycardia
(MedPage Today) -- Small case series in high-risk patients is promising for noninvasive tx (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 13, 2017 Category: Cardiology Source Type: news

A ‘ Game Changer ’ for Patients With Irregular Heart Rhythm
Rapid, erratic heartbeats — called ventricular tachycardia — can lead to sudden death. An experimental radiation treatment has eased the condition in five patients. (Source: NYT Health)
Source: NYT Health - December 13, 2017 Category: Consumer Health News Authors: GINA KOLATA Tags: Defibrillators Heart Radiation Medical Devices Source Type: news

Benefit of ECMO in Resuscitation from Refractory V Fib Cardiac Arrest
  The dawn of a new era Although ventricular tachycardia/ventricular fibrillation (v tach/v fib) constitutes only 25-35% of all cardiac arrests, more than 80% of all cardiac arrest survivors with favorable neurological function present with v tach/v fib.1,2 (See Figure 1, p. 12.) Despite that, only one third (approximately 30%) of patients presenting initially with v tach/v fib survive to hospital discharge with good neurological function. Compared to the other presenting rhythms (asystole and pulseless electrical activity) v tach/v fib is associated with the highest survival and stands out as the most important pos...
Source: JEMS Patient Care - December 1, 2017 Category: Emergency Medicine Authors: Demetris Yannopoulos, MD Tags: Patient Care Cardiac & Resuscitation Source Type: news

Benefit of ECMO in Resuscitation from Refractory V Fib Cardiac Arrest
  The dawn of a new era Although ventricular tachycardia/ventricular fibrillation (v tach/v fib) constitutes only 25-35% of all cardiac arrests, more than 80% of all cardiac arrest survivors with favorable neurological function present with v tach/v fib.1,2 (See Figure 1.) Despite that, only one third (approximately 30%) of patients presenting initially with v tach/v fib survive to hospital discharge with good neurological function. Compared to the other presenting rhythms (asystole and pulseless electrical activity) v tach/v fib is associated with the highest survival and stands out as the most important positive p...
Source: JEMS Patient Care - December 1, 2017 Category: Emergency Medicine Authors: Demetris Yannopoulos, MD Tags: Patient Care Cardiac & Resuscitation Source Type: news

Delayed onset of atrial fibrillation and ventricular tachycardia after an automobile lightning strike - Drigalla D, Essler SE, Stone CK.
BACKGROUND: Lightning strike is a rare medical emergency. The primary cause of death in lightning strike victims is immediate cardiac arrest. The mortality rate from lightning exposure can be as high as 30%, with up to 70% of patients left with significant... (Source: SafetyLit)
Source: SafetyLit - September 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Is BioSig for Real This Time With Its Pure EP?
A couple years ago, BioSig Technologies, Inc. was poised to apply for FDA clearance to market its technology to improve treatment of atrial fibrillation and ventricular tachycardia. Then its scientific advisors advised the Minneapolis company to put more work into that technology, a hardware-software combination designed to present clearer signals during electrophysiology studies and catheter ablation. The technology, Pure EP, is designed to cut through the background noise of the lab and its equipment during cardiac recordings, enabling physicians to target and neutralize the areas of the heart that are causing atria...
Source: MDDI - September 7, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: MD & M Minneapolis R Software Source Type: news

Milestone Pharmaceuticals Closes $55 Million Series C Financing
Proceeds to Fund Etripamil Phase 3 Development and Pre-Launch Market Development MONTREAL, August 1, 2017 -- (Healthcare Sales & Marketing Network) -- Milestone Pharmaceuticals Montreal, Canada, Inc., a clinical stage cardiovascular company, today anno... Biopharmaceuticals, Venture Capital, Personnel Milestone Pharmaceuticals, etripamil, supra-ventricular tachycardia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 1, 2017 Category: Pharmaceuticals Source Type: news

Ablation of Ventricular Tachycardia in Patients With MitraClip Ablation of Ventricular Tachycardia in Patients With MitraClip
Patients with mitral regurgitation are increasingly being treated with a MitraClip device. Is it feasible and safe to perform catheter ablation for ventricular tachycardia in these patients?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 29, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Chest Pain Drug Decreases Common Arrhythmias
A drug approved to treat chest pain reduces the incidence of a common arrhythmia called ventricular tachycardia in patients with an implantable cardioverter defibrillator, according to a study presented today at the Heart Rhythm Society ’s annual meeting. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - May 12, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Add-on Tx Cuts Exercise-Induced Arrhythmia in Genetic CPVT
(MedPage Today) -- Flecainide helps in catecholaminergic polymorphic ventricular tachycardia (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 11, 2017 Category: Cardiology Source Type: news

HRS 2017: Two-year registry data on Boston Scientific ’ s S-ICD
Data from a long-term post-approval registry study of the S-ICD subcutaneous pacemaker made by Boston Scientific (NYSE:BSX) showed high successful implantation rates and “acceptable” short-term complication rates, researchers said today at the annual Heart Rhythm Society conference in Chicago. The study looked at data from 1,637 S-ICD patients who met the criteria for implantable cardioverter defibrillator implantation, passed at least 1 electrocardiogram screening vector and had a life expectancy of more than 1 year. The mean follow-up time was 2 years and the study plans to follow patients out ...
Source: Mass Device - May 11, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Clinical Trials Boston Scientific Cardiac Rhythm Management hrs2017 Source Type: news

Zoll Medical wins Health Canada nod for next-gen AEDs
Zoll Medical said this week it won approval from Health Canada for its Zoll AED 3 and Zoll AED 3 BLS automated external defibrillators and launched them in the region. Both newly-cleared AEDs provide real-time feedback to communicate appropriate timing for effective CPR through audible and visual prompts, which the Chelmsford, Mass.-based company said can be critical to a patient’s survival. “We are extremely excited to add the Zoll AED 3 and the Zoll AED 3 BLS to our portfolio of automated external defibrillators. With the addition of these new devices, we are able to offer our public access and BLS ...
Source: Mass Device - March 23, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Regulatory/Compliance Resuscitation Zoll Medical Corp. Source Type: news

BioSig inks strategic partnership deal with Mayo Clinic
BioSig Technologies (OTCQB: BSGM) said today it inked a 10-year strategic agreement with the Mayo Clinic to develop advanced clinical features and applications for its Pure EP system. The new agreement expands on an earlier Advanced Clinical Research Program between BioSig and the Mayo clinic signed last March. “We are pleased to strengthen and broaden our relationship with Mayo Clinic and Mayo Ventures to grow our innovation capabilities and deliver superior medical technology,” founder & exec chair Kenneth Londoner said in a prepared statement. BioSig said it will work with Dr. Samuel Asirv...
Source: Mass Device - March 17, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Research & Development BioSig Technologies Source Type: news

Milestone Pharmaceuticals Announces Appointment of Joseph G. Oliveto as Chief Executive Officer
MONTREAL, March 7, 2017 -- (Healthcare Sales & Marketing Network) -- Milestone Pharmaceuticals USA, Inc., a clinical stage cardiovascular company, today announced the appointment of Joseph G. Oliveto as President and Chief Executive Officer, effective imm... Biopharmaceuticals, Cardiology, Personnel Milestone Pharmaceuticals, etripamil, paroxysmal supra-ventricular tachycardia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 7, 2017 Category: Pharmaceuticals Source Type: news

Francesca ’s story: Beating a heart tumor
Although her parents were warned she might not breathe when she was born, the moment Francesca Durkos came into this world, she let out a gutsy cry. “It was music to our ears,” says her mom. Michelle Carino Durkos was 40 weeks pregnant when she learned there was a tumor attached to her unborn daughter’s heart — a tumor so large that doctors near her home in Pensacola, Florida, were unsure if the baby would live. “It was a shock, because at 20 weeks everything was normal,” says Michelle. “We had a wonderful ultrasound; we saw all four chambers.” Yet, call it a mother’s i...
Source: Thrive, Children's Hospital Boston - February 1, 2017 Category: Pediatrics Authors: Emily Williams Tags: Our Patients’ Stories cardiac fibroma cardiac tumor Department of Cardiac Surgery Department of Cardiology Dr. Pedro del Nido Dr. Tal Geva echocardiogram ECMO Fetal Cardiology Program heart tumor neona ultrasound Source Type: news

BioSig seeks funding in the EU
BioSig Technologies (OTCQB: BSGM) said today it will engage in an institutional investor roadshow in the EU as it seeks funding for its proprietary Pure electrophysiology platform. The company is developing a cardiac signal acquisition and display system which is designed to assist electrophysiologists in making clinical decisions for patients with abnormal heart rates and rhythms, including atrial fibrillation and ventricular tachycardia. Minneapolis, Minn.-based BioSig said it will tour “major EU financial centers” between Feb. 27 and March 3, with board chair Kenneth Londoner delivering presentatio...
Source: Mass Device - January 30, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiovascular BioSig Technologies Source Type: news

Thermedical raises $3m for tissue ablation device
Thermedical raised $3 million in a new round of funding, according to regulatory filings. The private company is developing a treatment for ventricular tachycardia, an irregular heartbeat that can result in sudden cardiac arrest, and a treatment for soft tissue conditions, including liver, kidney, lung and uterine tumors. The company’s ablation system uses saline-enhanced radio frequency, according to Thermedical, to overcome the challenges of traditional ablation tools and to create large, controlled, symmetrical lesions.  The new round, which had its 1st sale on Jan. 13, will bring $700,000 to the company for ...
Source: Mass Device - January 25, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Funding Roundup Thermedical Source Type: news

Clinical trial testing new technique to treat life-threatening ventricular tachycardia
A landmark clinical trial is evaluating a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 23, 2017 Category: Science Source Type: news

Clinical trial testing new technique to treat life-threatening ventricular tachycardia
(Loyola University Health System) A landmark clinical trial is evaluating a new procedure to treat a life-threatening heart rhythm disorder called ventricular tachycardia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 23, 2017 Category: Global & Universal Source Type: news

BioSig taps Minnetronix to develop Pure EP prototype
BioSig Technologies (OTCQB: BSGM) issued a letter to its shareholders today, updating them on the company’s recent developments and revealing that it tapped Minnetronix to develop the 1st version of its Pure EP system. The Minneapolis-based company is developing a cardiac signal acquisition and display system which is designed to assist electrophysiologists in making clinical decisions for patients with abnormal heart rates and rhythms, including atrial fibrillation and ventricular tachycardia. Get the full story at our sister site, Medical Design & Outsourcing. The post BioSig taps Minne...
Source: Mass Device - January 20, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Patient Monitoring Wall Street Beat BioSig Technologies Minnetronix Inc. Source Type: news

Single vs. Multiple Ablations in Ventricular Tachycardia Single vs. Multiple Ablations in Ventricular Tachycardia
Are multiple catheter ablation procedures necessary in order to achieve long-term clinical success in ventricular tachycardia?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 15, 2016 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Loperamide abuse and cardiac dysrhythmia
3.5 out of 5 stars Cardiac Dysrhythmias After Loperamide Abuse — New York, 2008-2016. Eggleston W et al. MMWR 2016 Nov 18;65:1276-1277. Full Text Last week we reviewed a new paper showing that the number of cases of loperamide abuse reported to the National Poison Data System increased by 91% from the years 2000 to 2015. For reasons detailed in that review and in my recent Emergency Medicine News article on the topic, massive doses of loperamide can alleviate opioid withdrawal symptoms and also produce opioid-like effects. This very brief report has some interesting clinical and epidemiological nu...
Source: The Poison Review - November 25, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical cardiotoxicity ecg ekg electrocardiogram imodium loperamide Source Type: news

Young adult cardiac patient shares tips for ‘going it alone’ in the hospital
Zach with Sam the “Pawprints” dog Zachary Harper, 23, a young adult living with congenital heart disease, receives care at the Boston Children’s Hospital Heart Center. I was recently admitted to Boston Children’s Hospital. Though I am no stranger to these visits, they are still draining — both physically and mentally. You see, seven years ago, when I was 16, I went into sudden cardiac arrest at school. After an array of tests, my doctors concluded that a virus had attacked my heart. But five years later, another event led to a new diagnosis: arrhythmogenic right ventricular cardiomyo...
Source: Thrive, Children's Hospital Boston - November 21, 2016 Category: Pediatrics Authors: Zachary Harper Tags: Our Patients’ Stories Heart Center Heart Center’s Electrophysiology Program Pawprints Program Source Type: news

Genetesis lands $1m seed round for CardioFlux heart imaging device
Genetesis said today that it raised a $1.2 million seed round for its CardioFlux heart imaging device. Cincinatti-based Genetesis said the round was led by CincyTech and Mark Cuban’s Radical Investments and included Loud Capital, Danmar Capital, Wilson Sonsini Investment Company, Genetesis management and private angels. The CardioFlux device is designed to create a 3D map to characterize the heart’s underlying electrical activity in patients with myocardial ischemia, atrial fibrillation, ventricular tachycardia and other cardiac arrhythmias. The company said it plans to use the pro...
Source: Mass Device - November 14, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Funding Roundup Imaging Genetesis Source Type: news

Using heart tissue models to test heart disease treatments
Scientists are now able to create cardiac heart muscle cells from patients with heart disease. But cells alone aren’t enough to fully study cardiac disorders — especially rhythm disorders that require the activity of multiple cells assembled into tissues. William Pu, MD, of Boston Children’s Hospital’s Heart Center and his team are honing the art ofmodeling heart disease in a dish. With an accurate lab model, they hope to test drug therapies without posing a risk to living patients (or even live animals). Together with researchers at Harvard’s Wyss Institute, Pu’s lab recently modeled a...
Source: Mass Device - September 14, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog Vector Blog Source Type: news

Out-of-Hospital Cardiac Arrests Spike 14% Amid Heat WavesOut-of-Hospital Cardiac Arrests Spike 14% Amid Heat Waves
Heat waves significantly increased the risk of out-of-hospital cardiac arrest, especially in the elderly, but did not affect cardiac arrests with ventricular tachycardia or fibrillation. Heartwire from Medscape (Source: theHeart.org)
Source: theHeart.org - July 13, 2016 Category: Cardiology Tags: Cardiology News Source Type: news

Anticoagulation therapy after VT ablation yields fewer thrombotic events
San Francisco – Anticoagulation therapy is probably a good idea after ventricular tachycardia ablation in patients with risk factors or stroke, even if they don’t have atrial fibrillation, according... (Source: Clinical Neurology News)
Source: Clinical Neurology News - May 10, 2016 Category: Neurology Source Type: news

Halifax‑led study leads to better treatment for people with deadly heart condition
Dr. John Sapp, professor of cardiology, led an international study that found catheter ablation is a better treatment for ventricular tachycardia (VT) than high doses of antiarrhythmic drugs. (Source: Dalhousie University | Medical School News)
Source: Dalhousie University | Medical School News - May 5, 2016 Category: Universities & Medical Training Authors: Allison Gerrard Tags: News Source Type: news

Halifax ‑led study leads to better treatment for people with deadly heart condition
Dr. John Sapp, professor of cardiology, led an international study that found catheter ablation is a better treatment for ventricular tachycardia (VT) than high doses of antiarrhythmic drugs. (Source: Dalhousie University | Medical School News)
Source: Dalhousie University | Medical School News - May 5, 2016 Category: Universities & Medical Training Authors: Allison Gerrard Tags: News Source Type: news

Cardiac effects of loperamide overdose
3 out of 5 stars Not your regular high: cardiac dysrhythmias caused by loperamide. Wightman RS et al. Clin Toxicol 2016 Jun;54:454-458 Abstract Loperamide is an over-the-counter anti-diarrhea medication that is available without prescription under a variety of brand names including Imodium. In therapeutic doses, loperamide acts as a peripheral mu-opioid receptor agonist but doesn’t cross the blood-brain barrier (BBB). However, in massive overdose loperamide can enter the brain and cause central opioid toxicity, including altered mental status and respiratory. Although previously loperamide was thought ...
Source: The Poison Review - April 29, 2016 Category: Toxicology Authors: Leon Gussow Tags: Medical cardiac effects cardiogoxicity long QT loperamide overdose QRS interval qt interval Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. The r...
Source: JEMS Patient Care - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. The r...
Source: JEMS: Journal of Emergency Medical Services News - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

National Study Reviews Drug Administration during CPR
SEATTLE (KING 5) - In addition to CPR, paramedics routinely administer drugs to get the patient stabilized before reaching the hospital.  But do those drugs really improve the chances of survival? That was unknown until now. A national study led by UW finally has an answer—which is—it depends. When a King County Medic One team arrives at the scene of a cardiac arrest. CPR is standard. So is lidocaine to stabilize heart rhythm. “These drugs have been around-- lidocaine for probably 50 years, amiodarone for more than ten years-- and we used them with the best intention of wanting to save lives. T...
Source: JEMS Patient Care - April 5, 2016 Category: Emergency Medicine Tags: News Cardiac & Resuscitation Source Type: news

Survival after severe amitriptyline poisoning with prolonged ventricular tachycardia and cardiac arrest - Abeyaratne DD, Liyanapathirana C, Gamage A, Karunarathne P, Botheju M, Indrakumar J.
We report the first cas... (Source: SafetyLit)
Source: SafetyLit - March 19, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Strategies for the Prehospital Treatment of Stable Ventricular Tachycardia
Patients with stable v tach may experience a constellation of symptoms but generally don’t require cardioversion unless instability develops. Photo Matthew Strauss   You’re dispatched for an “ill” 55-yearold male. Upon arrival you find him sitting on the sofa in no apparent distress. He states he’s been feeling ill for the past three days. He’s otherwise asymptomatic. Initial assessment reveals an intact airway, normal breathing and clear lungs, no neurologic deficits, and no gross abnormalities on exposure. During the circulation exam, you note a regular rhythm with a fast hea...
Source: JEMS Patient Care - March 1, 2016 Category: Emergency Medicine Authors: Eric Cortez, MD Tags: Cardiac & Resuscitation Patient Care Source Type: news

Ablation Can Have Durable Benefit in Recurrent Ventricular Tachycardia (CME/CE)
(MedPage Today) -- But overall outcomes still "sobering" long term (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 11, 2016 Category: Cardiology Source Type: news

Mindfulness Practice During A Heart Attack: Or Me and My Mind Against My DNA
The author at age 26 sitting in Zazen Seiza style. This past August, at the age of 56, on the last day of my summer vacation, on the day after I ran yet another 5k, while I was attending my Saturday morning yoga class, I had a heart attack that could have killed me. It was a shock but not a surprise. Heart disease killed my older sister at 54, would have killed my dad at 56 had he not been life-flighted to UMass Medical Center where they shot him up on the helipad with a then experimental decoagulant, and heart disease killed my granddad on my first birthday. I had had a full medical work just the summer before and all sys...
Source: Healthy Living - The Huffington Post - October 30, 2015 Category: Consumer Health News Source Type: news

The Most Beautiful Dance I Ever Enjoyed With My Husband
This past weekend my husband, Dan danced at our friend's daughter's wedding. Well, if you consider swaying from side to side dancing, then it qualifies. While it may not seem so remarkable, the fact that Dan wiggled on a dance floor is amazing and wonderful! It was just five years ago that his life took a cruel turn and he suffered a devastating stroke. He couldn't walk, talk or eat. He had a feeding tube in his stomach, and we were told he was "gravely" ill. The stroke had affected his brain stem where bodily functions were regulated, paralyzed the optic nerve and traveled beyond. He received tPA -- tissue plas...
Source: Healthy Living - The Huffington Post - September 15, 2015 Category: Consumer Health News Source Type: news

Patient generated healthcare data
< I've often written about the IT strategies of Accountable Care Organizations and the need for a Care Management Medical Record which incorporates EHR data, patient generated data, customer relationship management features, protocols/guidelines and a workflow engine. Although I have yet to see mature products in the marketplace, components are evolving that will fundamentally change the way we deliver care. People know that I have been very transparent about my own medical history, as described in this Politico editorial. Here’s how I’m using Patient Generated Healthcare Data in my...
Source: Mass Device - July 27, 2015 Category: Medical Equipment Authors: MassDevice Tags: Blog Beth Israel Deaconess Medical Center Life as a Health Care CIO Source Type: news

Illustrated case report of phenol exposure
Phenol 3.5 out of 5 stars Phenol Toxicity Following Cutaneous Exposure to Creolin®:A Case Report. Vearrier D et al. J Med Toxicol 2015 Jun;11:227-231. Abstract This paper is worth looking at for the excellent color photographs of the partial thickness skin burns induced by exposure to Creolin®, which contains carbolic acid (phenol), sodium hydroxide, and isopropanol. A 9-year-old girl was brought to the emergency department because of respiratory distress and unresponsiveness. Symptoms came on quickly and started within 4 minutes of the mother pouring 8 oz Creolin® over the patients hair in an attempt to g...
Source: The Poison Review - June 18, 2015 Category: Toxicology Authors: Leon Tags: Medical coagulative necrosis creolin phenol surface burn Source Type: news